Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

1.

Decreased AKT1/mTOR pathway mRNA expression in short-term bipolar disorder.

Machado-Vieira R, Zanetti MV, Teixeira AL, Uno M, Valiengo LL, Soeiro-de-Souza MG, Oba-Shinjo SM, de Sousa RT, Zarate CA Jr, Gattaz WF, Marie SK.

Eur Neuropsychopharmacol. 2015 Feb 16. pii: S0924-977X(15)00028-0. doi: 10.1016/j.euroneuro.2015.02.002. [Epub ahead of print]

PMID:
25726893
2.

Lithium increases platelet serine-9 phosphorylated GSK-3β levels in drug-free bipolar disorder during depressive episodes.

de Sousa RT, Zanetti MV, Talib LL, Serpa MH, Chaim TM, Carvalho AF, Brunoni AR, Busatto GF, Gattaz WF, Machado-Vieira R.

J Psychiatr Res. 2015 Mar;62:78-83. doi: 10.1016/j.jpsychires.2015.01.016. Epub 2015 Feb 7.

PMID:
25691093
3.

Increased plasma levels of soluble TNF receptors 1 and 2 in bipolar depression and impact of lithium treatment.

Teixeira AL, de Souza RT, Zanetti MV, Brunoni AR, Busatto GF, Zarate CA Jr, Gattaz WF, Machado-Vieira R.

Hum Psychopharmacol. 2015 Jan;30(1):52-6. doi: 10.1002/hup.2450.

PMID:
25572309
4.

Bimodal Effect of Lithium Plasma Levels on Hippocampal Glutamate Concentrations in Bipolar II Depression: A Pilot Study.

Zanetti MV, Otaduy MC, de Sousa RT, Gattaz WF, Busatto GF, Leite CC, Machado-Vieira R.

Int J Neuropsychopharmacol. 2014 Oct 31. pii: pyu058. doi: 10.1093/ijnp/pyu058. [Epub ahead of print]

PMID:
25522399
5.

Cognitive dysfunction in depression - pathophysiology and novel targets.

Carvalho AF, Miskowiak KK, Hyphantis TN, Kohler CA, Alves GS, Bortolato B, G Sales PM, Machado-Vieira R, Berk M, McIntyre RS.

CNS Neurol Disord Drug Targets. 2014;13(10):1819-35.

PMID:
25470397
6.

Shank3 as a potential biomarker of antidepressant response to ketamine and its neural correlates in bipolar depression.

Ortiz R, Niciu MJ, Lukkahati N, Saligan LN, Nugent AC, Luckenbaugh DA, Machado-Vieira R, Zarate CA Jr.

J Affect Disord. 2014 Oct 16;172C:307-311. doi: 10.1016/j.jad.2014.09.015. [Epub ahead of print]

PMID:
25451430
7.

Purinergic system dysfunction in mood disorders: a key target for developing improved therapeutics.

Ortiz R, Ulrich H, Zarate CA Jr, Machado-Vieira R.

Prog Neuropsychopharmacol Biol Psychiatry. 2015 Mar 3;57:117-31. doi: 10.1016/j.pnpbp.2014.10.016. Epub 2014 Nov 7.

PMID:
25445063
8.

Cytokines in bipolar disorder: paving the way for neuroprogression.

Barbosa IG, Bauer ME, Machado-Vieira R, Teixeira AL.

Neural Plast. 2014;2014:360481. doi: 10.1155/2014/360481. Epub 2014 Sep 9.

9.

Elevated neurotrophin-3 and neurotrophin 4/5 levels in unmedicated bipolar depression and the effects of lithium.

Loch AA, Zanetti MV, de Sousa RT, Chaim TM, Serpa MH, Gattaz WF, Teixeira AL, Machado-Vieira R.

Prog Neuropsychopharmacol Biol Psychiatry. 2015 Jan 2;56:243-6. doi: 10.1016/j.pnpbp.2014.09.014. Epub 2014 Oct 5.

PMID:
25290636
10.

BDNF blood levels after non-invasive brain stimulation interventions in major depressive disorder: A systematic review and meta-analysis.

Brunoni AR, Baeken C, Machado-Vieira R, Gattaz WF, Vanderhasselt MA.

World J Biol Psychiatry. 2015 Feb;16(2):114-22. doi: 10.3109/15622975.2014.958101. Epub 2014 Sep 29.

PMID:
25264290
11.

Lithium efficacy in bipolar depression with flexible dosing: A six-week, open-label, proof-of-concept study.

Machado-Vieira R, Zanetti MV, DE Sousa RT, Soeiro-DE-Souza MG, Moreno RA, Busatto GF, Gattaz WF.

Exp Ther Med. 2014 Oct;8(4):1205-1208. Epub 2014 Jul 24.

12.

Adipokines as emerging depression biomarkers: a systematic review and meta-analysis.

Carvalho AF, Rocha DQ, McIntyre RS, Mesquita LM, Köhler CA, Hyphantis TN, Sales PM, Machado-Vieira R, Berk M.

J Psychiatr Res. 2014 Dec;59:28-37. doi: 10.1016/j.jpsychires.2014.08.002. Epub 2014 Aug 19.

PMID:
25183029
13.

Assessment of non-BDNF neurotrophins and GDNF levels after depression treatment with sertraline and transcranial direct current stimulation in a factorial, randomized, sham-controlled trial (SELECT-TDCS): an exploratory analysis.

Brunoni AR, Machado-Vieira R, Zarate CA Jr, Vieira EL, Valiengo L, Benseñor IM, Lotufo PA, Gattaz WF, Teixeira AL.

Prog Neuropsychopharmacol Biol Psychiatry. 2015 Jan 2;56:91-6. doi: 10.1016/j.pnpbp.2014.08.009. Epub 2014 Aug 27.

PMID:
25172025
14.

Reduced cerebrospinal fluid levels of brain-derived neurotrophic factor is associated with cognitive impairment in late-life major depression.

Diniz BS, Teixeira AL, Machado-Vieira R, Talib LL, Radanovic M, Gattaz WF, Forlenza OV.

J Gerontol B Psychol Sci Soc Sci. 2014 Nov;69(6):845-51. doi: 10.1093/geronb/gbu096. Epub 2014 Aug 22.

PMID:
25149921
15.

Decreased plasma neurotrophin-4/5 levels in bipolar disorder patients in mania.

Barbosa IG, Morato IB, Huguet RB, Rocha FL, Machado-Vieira R, Teixeira AL.

Rev Bras Psiquiatr. 2014 Oct-Dec;36(4):340-3. doi: 10.1590/1516-4446-2014-1380. Epub 2014 Jul 29.

16.

D-serine plasma concentration is a potential biomarker of (R,S)-ketamine antidepressant response in subjects with treatment-resistant depression.

Moaddel R, Luckenbaugh DA, Xie Y, Villaseñor A, Brutsche NE, Machado-Vieira R, Ramamoorthy A, Lorenzo MP, Garcia A, Bernier M, Torjman MC, Barbas C, Zarate CA Jr, Wainer IW.

Psychopharmacology (Berl). 2015 Jan;232(2):399-409. doi: 10.1007/s00213-014-3669-0. Epub 2014 Jul 24.

PMID:
25056852
17.

Targeting mitochondrially mediated plasticity to develop improved therapeutics for bipolar disorder.

de Sousa RT, Machado-Vieira R, Zarate CA Jr, Manji HK.

Expert Opin Ther Targets. 2014 Oct;18(10):1131-47. doi: 10.1517/14728222.2014.940893. Epub 2014 Jul 24.

PMID:
25056514
18.

Reduced activities of phospholipases A2 in platelets of drug-naïve bipolar disorder patients.

Ikenaga EH, Talib LL, Ferreira AS, Machado-Vieira R, Forlenza OV, Gattaz WF.

Bipolar Disord. 2015 Feb;17(1):97-101. doi: 10.1111/bdi.12229. Epub 2014 Jul 8.

PMID:
25041493
19.

Lithium increases leukocyte mitochondrial complex I activity in bipolar disorder during depressive episodes.

de Sousa RT, Streck EL, Zanetti MV, Ferreira GK, Diniz BS, Brunoni AR, Busatto GF, Gattaz WF, Machado-Vieira R.

Psychopharmacology (Berl). 2015 Jan;232(1):245-50. doi: 10.1007/s00213-014-3655-6. Epub 2014 Jun 26.

PMID:
24961563
20.

Baseline vitamin B12 and folate levels do not predict improvement in depression after a single infusion of ketamine.

Lundin NB, Niciu MJ, Luckenbaugh DA, Ionescu DF, Richards EM, Vande Voort JL, Brutsche NE, Machado-Vieira R, Zarate CA Jr.

Pharmacopsychiatry. 2014 Jul;47(4-5):141-4. doi: 10.1055/s-0034-1377042. Epub 2014 Jun 23.

PMID:
24955551
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk